HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Direct determination of intracellular daunorubicin in intact confluent monolayers of AT1 prostate carcinoma cells using a multiwell-multilabel counter.

Abstract
The cytostatic drug daunorubicin exerts its toxic action by intercalating into the DNA. The efficacy of daunorubicin depends on the intracellular amount in the tumor cell. Here we have evaluated the use of a multiwell-multilabel reader for the direct determination of the fluorescent cytostatic drug daunorubicin in a prostate carcinoma cell line (AT1 R-3327 Dunning prostate carcinoma cells) grown on 24-well plates. We present evidence that this simple fluorescent parameter is a good measure for the toxicologically relevant amount of the drug intercalated into the DNA and, therefore, is a good predictor for the drug's cytotoxicity. The amount of cationic cytostatics in a tumor cell is primarily a function of the efflux pump protein p-gycoprotein (pGP). Therefore, it is of great value that the assay is also suitable for the estimation of the multidrug resistance efflux pump (pGP) activity.
AuthorsC Sauvant, O Thews, C Wirth, M Gekle
JournalAnalytical biochemistry (Anal Biochem) Vol. 381 Issue 1 Pg. 81-5 (Oct 01 2008) ISSN: 1096-0309 [Electronic] United States
PMID18634747 (Publication Type: Journal Article)
Chemical References
  • ATP Binding Cassette Transporter, Subfamily B, Member 1
  • Cell Extracts
  • DNA, Neoplasm
  • Verapamil
  • Daunorubicin
Topics
  • ATP Binding Cassette Transporter, Subfamily B, Member 1 (metabolism)
  • Animals
  • Cell Extracts
  • Cell Line, Tumor
  • Cell Proliferation (drug effects)
  • Chemistry Techniques, Analytical (instrumentation, methods)
  • DNA, Neoplasm (metabolism)
  • Daunorubicin (analysis)
  • Intracellular Space (drug effects, metabolism)
  • Male
  • Prostatic Neoplasms (chemistry)
  • Rats
  • Spectrometry, Fluorescence
  • Subcellular Fractions
  • Time Factors
  • Verapamil (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: